{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:14:49Z","timestamp":1789578889380,"version":"build-2803163510"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11154-022-09715-y","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T15:03:36Z","timestamp":1645887816000},"page":"251-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-4226","authenticated-orcid":false,"given":"Sebasti\u00e3o Freitas","family":"de Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-2515","authenticated-orcid":false,"given":"M\u00e1rcia Marly Winck","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4069-7490","authenticated-orcid":false,"given":"Matheus Ant\u00f4nio Souto","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5207-8307","authenticated-orcid":false,"given":"Ana Karine Lin Winck","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-6766","authenticated-orcid":false,"given":"Bruna Barcelo","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"key":"9715_CR1","unstructured":"World Health Organization. Statement on the second meeting of the International Health Regulations.\u00a0Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2005.\u00a0https:\/\/www.who.int\/news-room\/detail\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov. (Assessed 12 Jul 2021)."},{"key":"9715_CR2","doi-asserted-by":"crossref","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427.","DOI":"10.1016\/j.clim.2020.108427"},{"key":"9715_CR3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152.","journal-title":"Front Public Health"},{"key":"9715_CR4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12916-020-01697-5","volume":"18","author":"I Kyrou","year":"2020","unstructured":"Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva HS. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020;18:220.","journal-title":"BMC Med"},{"key":"9715_CR5","doi-asserted-by":"crossref","unstructured":"Klonoff DC, Umpierrez GE. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity. Metabolism. 2020;108:154224.","DOI":"10.1016\/j.metabol.2020.154224"},{"key":"9715_CR6","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.jinf.2020.03.059","volume":"81","author":"M Zuin","year":"2020","unstructured":"Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis. J Infect. 2020;81:e84\u20136.","journal-title":"J Infect"},{"key":"9715_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89:453\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"9715_CR8","first-page":"803","volume":"22","author":"L Scappaticcio","year":"2021","unstructured":"Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev EndocrMetabDisord. 2021;22:803\u201315.","journal-title":"Rev EndocrMetabDisord"},{"key":"9715_CR9","first-page":"703","volume":"22","author":"V Guarnotta","year":"2021","unstructured":"Guarnotta V, Ferrigno R, Martino M, et al. Glucocorticoid excess and COVID-19 disease. Rev EndocrMetabDisord. 2021;22:703\u201314.","journal-title":"Rev EndocrMetabDisord"},{"key":"9715_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544\u201351.","journal-title":"Hum Reprod"},{"key":"9715_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","volume":"111","author":"RS Legro","year":"2001","unstructured":"Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111:607\u201313.","journal-title":"Am J Med"},{"key":"9715_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1358\/dot.2009.45.10.1429463","volume":"45","author":"V De Leo","year":"2009","unstructured":"De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. Drugs Today (Barc). 2009;45:763\u201375.","journal-title":"Drugs Today (Barc)"},{"key":"9715_CR13","first-page":"118","volume":"18","author":"X Ruan","year":"2009","unstructured":"Ruan X, Dai Y. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome. Med PrincPract. 2009;18:118\u201322.","journal-title":"Med PrincPract"},{"key":"9715_CR14","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","volume":"7","author":"Q Wu","year":"2017","unstructured":"Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7:9110.","journal-title":"Sci Rep"},{"key":"9715_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","volume":"17","author":"D Glintborg","year":"2018","unstructured":"Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovasc Diabetol. 2018;17:37.","journal-title":"Cardiovasc Diabetol"},{"key":"9715_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","volume":"150","author":"MA Ganie","year":"2019","unstructured":"Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150:333\u201344.","journal-title":"Indian J Med Res"},{"key":"9715_CR17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/humupd\/dmab004","volume":"27","author":"SF de Medeiros","year":"2021","unstructured":"de Medeiros SF, Rodgers RJ, Norman RJ. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome. Hum Reprod Update. 2021;27:771\u201396.","journal-title":"Hum Reprod Update"},{"key":"9715_CR18","doi-asserted-by":"crossref","unstructured":"de Medeiros SF, Yamamoto MMW, Souto de Medeiros MA, Barbosa BB, Soares JM, Baracat EC. Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age. Endocr Connect. 2020;9:74\u201389.","DOI":"10.1530\/EC-19-0496"},{"key":"9715_CR19","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.21786\/bbrc\/13.4\/12","volume":"13","author":"AA Alahmadi","year":"2020","unstructured":"Alahmadi AA. The common pathological factors between polycystic ovary syndrome and COVID-19 infection: A review. Biosc Biotech Res Comm. 2020;13:1708\u201316.","journal-title":"Biosc Biotech Res Comm"},{"key":"9715_CR20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-20-1163","volume":"184","author":"A Subramanian","year":"2021","unstructured":"Subramanian A, Anand A, Adderley NJ, Okoth K, Toulis KA, Gokhale K, et al. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol. 2021;184:637\u201345.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR21","doi-asserted-by":"crossref","unstructured":"Ballering AV, Oertelt-Prigione S, Olde Hartman TC, Rosmalen JGM. Lifelines corona research initiative. Sex and gender-related differences in COVID-19 diagnoses and SARS-CoV-2 testing practices during the first wave of the pandemic: The Dutch lifelines COVID-19 Cohort Study.\u00a0J Womens Health (Larchmt). 2021;30:1686\u20131692.","DOI":"10.1089\/jwh.2021.0226"},{"key":"9715_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"},{"key":"9715_CR23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","volume":"53","author":"D Wu","year":"2020","unstructured":"Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53:368\u201370.","journal-title":"J Microbiol Immunol Infect"},{"key":"9715_CR24","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323:1775\u20136.","journal-title":"JAMA"},{"key":"9715_CR25","unstructured":"World Health Organization. WHO, coronavirus (COVID-19) dashboard vaccination date.\u00a02021."},{"key":"9715_CR26","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.15585\/mmwr.mm6939e2","volume":"69","author":"RT Leeb","year":"2020","unstructured":"Leeb RT, Price S, Sliwa S, et al. COVID-19 Trends among school-aged children \u2013 United States, 1 Mar \u2013 19 Sep\u00a02020. MMWR Morb Mortal Wkly Rep. 2020;69:1410\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9715_CR27","doi-asserted-by":"crossref","unstructured":"Ding Y, Yan Hand Guo W. Clinical characteristics of children with COVID-19: a meta-analysis. Front Pediatr. 2020;8:431.","DOI":"10.3389\/fped.2020.00431"},{"key":"9715_CR28","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa2006100","volume":"382","author":"DF Gudbjartsson","year":"2020","unstructured":"Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020;382:2302\u201315.","journal-title":"N Engl J Med"},{"key":"9715_CR29","doi-asserted-by":"crossref","unstructured":"Badal S, Thapa Bajgain K, Badal S, Thapa R, Bajgain BB, Santana MJ. Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis. J Clin Virol. 2021;135:104715.","DOI":"10.1016\/j.jcv.2020.104715"},{"key":"9715_CR30","doi-asserted-by":"crossref","unstructured":"Sah P, Fitzpatrick MC, Zimmer CF, et al. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.\u00a0Proc Natl Acad Sci U S A. 2021;118:e2109229118.","DOI":"10.1073\/pnas.2109229118"},{"key":"9715_CR31","doi-asserted-by":"crossref","unstructured":"Kalish H, Klumpp-Thomas C, Hunsberger S, Baus HA, Fay MP, Siripong N, Wang J, Hicks J, Mehalko J, Travers J, et al. Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci Transl Med. 2021;13(601):eabh3826.","DOI":"10.1126\/scitranslmed.abh3826"},{"key":"9715_CR32","doi-asserted-by":"crossref","unstructured":"Chen, MA, Haupert RS, Zimmerman L, BSc, Shi X, PhD, Fritsche LG, PhD, Mukherjee B, PhD. Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: A meta-analysis and systematic review. 2021","DOI":"10.1101\/2021.11.15.21266377"},{"key":"9715_CR33","doi-asserted-by":"crossref","unstructured":"Perlis RH, Green J, Santillana M, et al. Persistence of symptoms up to 10 months following acute COVID-19 illness. Preprint.\u00a0medRxiv. 2021;2021.03.07.21253072. Published 8 Mar\u00a02021.","DOI":"10.1101\/2021.03.07.21253072"},{"key":"9715_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13054-020-2737-6","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24:22.","journal-title":"Crit Care"},{"key":"9715_CR35","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117:11727\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9715_CR36","first-page":"288","volume":"35","author":"MK Bohn","year":"2020","unstructured":"Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms underlying disease severity and progression. Physiology (Bethesda). 2020;35:288\u2013301.","journal-title":"Physiology (Bethesda)"},{"key":"9715_CR37","first-page":"95","volume":"22","author":"F Ciceri","year":"2020","unstructured":"Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020;22:95\u20137.","journal-title":"Crit Care Resusc"},{"issue":"20","key":"9715_CR38","first-page":"30602","volume":"S0735\u20136757","author":"E Yonas","year":"2020","unstructured":"Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Gutierrez EJ, et al. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2020;S0735\u20136757(20):30602\u201311.","journal-title":"Am J Emerg Med"},{"key":"9715_CR39","doi-asserted-by":"crossref","first-page":"117954842095916","DOI":"10.1177\/1179548420959165","volume":"14","author":"R Pranata","year":"2020","unstructured":"Pranata R, Supriyadi R, Huang I, Permana H, Lim MA, Yonas E, et al. The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: A meta-analysis. Clin Med Insights Circ Respir Pulm Med. 2020;14:1179548420959165.","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"9715_CR40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.12997\/jla.2020.9.3.435","volume":"9","author":"GJ Choi","year":"2020","unstructured":"Choi GJ, Kim HM, Kang H. The potential role of dyslipidemia in COVID-19 severity: An umbrella review of systematic reviews. J Lipid Atheroscler. 2020;9:435\u201348.","journal-title":"J Lipid Atheroscler"},{"key":"9715_CR41","unstructured":"Cennimo DJ. Bronze MS. Coronavirus disease 2019 (COVID-19). 2021, Emedicine Medscape. 2021;2500114-print."},{"key":"9715_CR42","doi-asserted-by":"crossref","unstructured":"Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China.\u00a0Pediatrics. 2020;145:e20200702.","DOI":"10.1542\/peds.2020-0702"},{"key":"9715_CR43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2020.4344","volume":"323","author":"E Livingston","year":"2020","unstructured":"Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323:1335.","journal-title":"JAMA"},{"key":"9715_CR44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mad.2005.11.001","volume":"127","author":"P Saule","year":"2006","unstructured":"Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev. 2006;127:274\u201381.","journal-title":"Mech Ageing Dev"},{"key":"9715_CR45","doi-asserted-by":"crossref","first-page":"27142","DOI":"10.1073\/pnas.1911083116","volume":"116","author":"S Nickbakhsh","year":"2019","unstructured":"Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019;116:27142\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9715_CR46","doi-asserted-by":"crossref","unstructured":"Wray S, Arrowsmith S. The physiological mechanisms of the sex-based difference in outcomes of COVID19 infection. Front Physiol. 2021;12:627260.","DOI":"10.3389\/fphys.2021.627260"},{"key":"9715_CR47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region. Italy JAMA. 2020;323:1574\u201381.","journal-title":"Italy JAMA"},{"key":"9715_CR48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jwh.2020.8974","volume":"30","author":"A Tejpal","year":"2021","unstructured":"Tejpal A, Gianos E, Cerise J, Hirsch JS, Rosen S, Kohn N, et al. Sex-based differences in COVID-19 outcomes. J Womens Health (Larchmt). 2021;30:492\u2013501.","journal-title":"J Womens Health (Larchmt)"},{"key":"9715_CR49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.immuni.2020.08.003","volume":"53","author":"MJ Bunders","year":"2020","unstructured":"Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53:487\u201395.","journal-title":"Immunity"},{"key":"9715_CR50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-020-02536-6","volume":"71","author":"MS Mohamed","year":"2021","unstructured":"Mohamed MS, Moulin TC, Schi\u00f6th HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021;71:3\u20138.","journal-title":"Endocrine"},{"key":"9715_CR51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40618-020-01383-6","volume":"44","author":"C Foresta","year":"2021","unstructured":"Foresta C, Rocca MS, Di Nisio A. Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome. J Endocrinol Invest. 2021;44:951\u20136.","journal-title":"J Endocrinol Invest"},{"key":"9715_CR52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/andr.12811","volume":"9","author":"A Salonia","year":"2021","unstructured":"Salonia A, Corona G, Giwercman A, Maggi M, Minhas S, Nappi RE, et al. SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project. Andrology. 2021;9:19\u201322.","journal-title":"Andrology"},{"key":"9715_CR53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.seminoncol.2020.06.002","volume":"47","author":"JD Strope","year":"2020","unstructured":"Strope JD, Chau CH, Figg WD. Are sex discordant outcomes in COVID-19 related to sex hormones? Semin Oncol. 2020;47:335\u201340.","journal-title":"Semin Oncol"},{"key":"9715_CR54","doi-asserted-by":"publisher","unstructured":"Gagliardi MC, Tieri P, Ortona E, Ruggieri A. ACE2 expression and sex disparity in COVID-19.\u00a0Cell Death Discov. 2020;6:37. Published 26 May\u00a02020.\u00a0https:\/\/doi.org\/10.1038\/s41420-020-0276-1.","DOI":"10.1038\/s41420-020-0276-1"},{"key":"9715_CR55","doi-asserted-by":"crossref","unstructured":"Baratchian M, McManus JM, Berk MP, et al. Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.\u00a0Sci Rep. 2021;11(1):111302020;27:E1\u20133.","DOI":"10.1038\/s41598-021-90491-1"},{"key":"9715_CR56","first-page":"E1","volume":"27","author":"N Sharifi","year":"2020","unstructured":"Sharifi N, Ryan CJ. Androgen hazards with COVID-19. Endocr Relat Cancer. 2020;27:E1-3.","journal-title":"EndocrRelatCancer"},{"key":"9715_CR57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaad.2020.04.032","volume":"83","author":"CG Wambier","year":"2020","unstructured":"Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020;83:308\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"9715_CR58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ddr.21688","volume":"81","author":"CG Wambier","year":"2020","unstructured":"Wambier CG, Goren A, Va\u00f1o-Galv\u00e1n S, Ramos PM, Ossimetha A, Nau G, et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020;81:771\u20136.","journal-title":"Drug Dev Res"},{"key":"9715_CR59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AOG.0000000000004275","volume":"137","author":"C Gotluru","year":"2021","unstructured":"Gotluru C, Roach A, Cherry SH, Runowicz CD. Sex, hormones, immune functions, and susceptibility to coronavirus disease 2019 (COVID-19)-related morbidity. Obstet Gynecol. 2021;137:423\u20139.","journal-title":"Obstet Gynecol"},{"key":"9715_CR60","doi-asserted-by":"crossref","unstructured":"Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology. 2020;161:bqaa127.","DOI":"10.1210\/endocr\/bqaa127"},{"key":"9715_CR61","doi-asserted-by":"crossref","unstructured":"Pagano MT, Peruzzu D, Ruggieri A, Ortona E, Gagliardi MC. Vitamin D and sex differences in COVID-19. Front Endocrinol (Lausanne). 2020;11:567824.","DOI":"10.3389\/fendo.2020.567824"},{"key":"9715_CR62","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/oby.22856","volume":"28","author":"IL Kruglikov","year":"2020","unstructured":"Kruglikov IL, Scherer PE. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity (Silver Spring). 2020;28:1187\u201390.","journal-title":"Obesity (Silver Spring)"},{"key":"9715_CR63","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"9715_CR64","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","volume":"10","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10:338\u201349.","journal-title":"Lancet Infect Dis"},{"key":"9715_CR65","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.tjog.2020.09.006","volume":"59","author":"WH Chang","year":"2020","unstructured":"Chang WH. A review of vaccine effects on women in light of the COVID-19 pandemic. Taiwan J Obstet Gynecol. 2020;59:812\u201320.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"9715_CR66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40246-018-0185-z","volume":"13","author":"H Schurz","year":"2019","unstructured":"Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, M\u00f6ller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13:2.","journal-title":"Hum Genomics"},{"key":"9715_CR67","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/oby.22844","volume":"28","author":"AE Malavazos","year":"2020","unstructured":"Malavazos AE, Corsi Romanelli MM, Bandera F, Iacobellis G. Targeting the adipose tissue in COVID-19. Obesity (Silver Spring). 2020;28:1178\u20139.","journal-title":"Obesity (Silver Spring)"},{"key":"9715_CR68","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/oby.22843","volume":"28","author":"PM Ryan","year":"2020","unstructured":"Ryan PM, Caplice NM. Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019? Obesity (Silver Spring). 2020;28:1191\u20134.","journal-title":"Obesity (Silver Spring)"},{"key":"9715_CR69","doi-asserted-by":"crossref","unstructured":"Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A. Commentary: Obesity: The achilles heel for COVID-19? Metabolism. 2020;108:154251.","DOI":"10.1016\/j.metabol.2020.154251"},{"key":"9715_CR70","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/oby.22818","volume":"28","author":"W Dietz","year":"2020","unstructured":"Dietz W, Santos-Burgoa C. Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring). 2020;28:1005.","journal-title":"Obesity (Silver Spring)"},{"key":"9715_CR71","doi-asserted-by":"crossref","unstructured":"Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21:e13128.","DOI":"10.1111\/obr.13128"},{"key":"9715_CR72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2213-8587(21)00089-9","volume":"9","author":"M Gao","year":"2021","unstructured":"Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O\u2019Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6\u00b79 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9715_CR73","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2147\/JIR.S282710","volume":"14","author":"A De Lorenzo","year":"2021","unstructured":"De Lorenzo A, Estato V, Castro-Faria-Neto HC, Tibirica E. Obesity-related inflammation and endothelial dysfunction in COVID-19: Impact on disease severity. J Inflamm Res. 2021;14:2267\u201376.","journal-title":"J Inflamm Res"},{"key":"9715_CR74","doi-asserted-by":"crossref","unstructured":"Brand\u00e3o SCS, Godoi ETAM, de Oliveira Cordeiro LH, Bezerra CS, de Oliveira Xavier Ramos J, de Arruda GFA, et al. COVID-19 and obesity: the meeting of two pandemics. Arch Endocrinol Metab. 2020:2359\u20133997000000318.","DOI":"10.20945\/2359-3997000000318"},{"key":"9715_CR75","first-page":"85","volume":"53","author":"CWS Hoong","year":"2021","unstructured":"Hoong CWS, Hussain I, Aravamudan VM, Phyu EE, Lin JHX, Koh H. Obesity is associated with poor covid-19 outcomes: A systematic review and meta-analysis. HormMetab Res. 2021;53:85\u201393.","journal-title":"HormMetab Res"},{"key":"9715_CR76","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","volume":"69","author":"S Garg","year":"2020","unstructured":"Garg S, Kim L, Whitaker M, O\u2019Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458\u201364.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9715_CR77","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City area. JAMA. 2020;323:2052\u20139.","journal-title":"JAMA"},{"issue":"15","key":"9715_CR78","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciaa415","volume":"71","author":"J Lighter","year":"2020","unstructured":"Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71(15):896\u20137.","journal-title":"Clin Infect Dis"},{"key":"9715_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.01.007","author":"IS Atmosudigdo","year":"2021","unstructured":"Atmosudigdo IS, Pranata R, Lim MA, Henrina J, Yonas E, Vania R, et al. Dyslipidemia increases the risk of severe COVID-19: A systematic review, meta-analysis, and meta-regression. J Clin Exp Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.jceh.2021.01.007.","journal-title":"J Clin Exp Hepatol"},{"key":"9715_CR80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","volume":"136","author":"LB Daniels","year":"2020","unstructured":"Daniels LB, Sitapati AM, Zhang J, Zou J, Bui QM, Ren J, et al. Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients. Am J Cardiol. 2020;136:149\u201355.","journal-title":"Am J Cardiol"},{"key":"9715_CR81","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ehjcvp\/pvaa042","volume":"6","author":"V Castiglione","year":"2020","unstructured":"Castiglione V, Chiriac\u00f2 M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother. 2020;6:258\u20139.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"9715_CR82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","volume":"134","author":"CS Kow","year":"2020","unstructured":"Kow CS, Hasan SS. Meta-analysis of effect of statins in patients with COVID-19. Am J Cardiol. 2020;134:153\u20135.","journal-title":"Am J Cardiol"},{"issue":"8","key":"9715_CR83","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1096\/fj.202001451","volume":"34","author":"AV Sorokin","year":"2020","unstructured":"Sorokin AV, Karathanasis SK, Yang ZH, Freeman L, Kotani K, et al. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34(8):9843\u201353.","journal-title":"FASEB J"},{"key":"9715_CR84","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.dsx.2020.07.054","volume":"14","author":"TI Hariyanto","year":"2020","unstructured":"Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. DibetMetab Syndrome: Clin Res Rev. 2020;14:1463\u20135.","journal-title":"DibetMetab Syndrome: Clin Res Rev"},{"key":"9715_CR85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imm.12394","volume":"144","author":"K Hodgson","year":"2015","unstructured":"Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144:171\u201385.","journal-title":"Immunology"},{"key":"9715_CR86","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","volume":"41","author":"LM Muller","year":"2005","unstructured":"Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281\u20138.","journal-title":"Clin Infect Dis"},{"key":"9715_CR87","doi-asserted-by":"crossref","unstructured":"Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes. Metabolism. 2020;107:154217.","DOI":"10.1016\/j.metabol.2020.154217"},{"key":"9715_CR88","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","volume":"43","author":"GP Adini","year":"2020","unstructured":"Adini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43:867\u20139.","journal-title":"J Endocrinol Invest"},{"key":"9715_CR89","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc20-0723","volume":"43","author":"C Sardu","year":"2020","unstructured":"Sardu C, D\u2019Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Outcomes in patients with hyperglycemia affected by COVID-19: Can we do more on glycemic control? Diabetes Care. 2020;43:1408\u201315.","journal-title":"Diabetes Care"},{"key":"9715_CR90","doi-asserted-by":"crossref","unstructured":"Morra ME, Van Thanh L, Kamel MG, Ghazy AA, Altibi AMA, Dat LM, et al. Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis. Rev Med Virol. 2018;28:e1977.","DOI":"10.1002\/rmv.1977"},{"key":"9715_CR91","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40618-020-01276-8","volume":"43","author":"R Pal","year":"2020","unstructured":"Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43:1027\u201331.","journal-title":"J Endocrinol Invest"},{"key":"9715_CR92","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-20-0335","volume":"183","author":"A Lania","year":"2020","unstructured":"Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183:381\u20137.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/eje.0.1480383","volume":"148","author":"G Mazziotti","year":"2003","unstructured":"Mazziotti G, Sorvillo F, Naclerio C, Farzati A, Cioffi M, Perna R, et al. Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto\u2019s thyroiditis. Eur J Endocrinol. 2003;148:383\u20138.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR94","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1530\/EC-21-0301","volume":"10","author":"CL Clausen","year":"2021","unstructured":"Clausen CL, Rasmussen \u00c5K, Johannsen TH, et al. Thyroid function in COVID-19 and the association with cytokine levels and mortality. Endocr Connect. 2021;10:1234\u201342.","journal-title":"Endocr Connect"},{"key":"9715_CR95","doi-asserted-by":"crossref","unstructured":"Borntein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld Al, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020a;8:546\u201350.","DOI":"10.1016\/S2213-8587(20)30152-2"},{"key":"9715_CR96","first-page":"411","volume":"49","author":"XH Yao","year":"2020","unstructured":"Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49:411\u20137.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"9715_CR97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-16-0969","volume":"176","author":"I Bancos","year":"2017","unstructured":"Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, Lord JM, et al. Primary drenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol. 2017;176:471\u201380.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR98","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1530\/EJE-20-0361","volume":"183","author":"W Arlt","year":"2020","unstructured":"Arlt W, Baldeweg SE, Pearce SHS, Simpson HL. Endocrinology in the time of COVID-19: Management of adrenal insufficiency. Eur J Endocrinol. 2020;183:G25-32.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR99","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.mehy.2004.04.009","volume":"63","author":"R Wheatland","year":"2004","unstructured":"Wheatland R. Molecular mimicry of ACTH in SARS - implications for corticosteroid treatment and prophylaxis. Med Hypotheses. 2004;63:855\u201362.","journal-title":"Med Hypotheses"},{"key":"9715_CR100","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EC-16-0054","volume":"5","author":"Arlt W; Society for Endocrinology Clinical Committee","year":"2016","unstructured":"Arlt W. Society for endocrinology clinical committee. Society for endocrinology endocrine emergency guidance: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect. 2016;5:G1-3.","journal-title":"Endocr Connect"},{"key":"9715_CR101","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-20-0352","volume":"183","author":"J Newell-Price","year":"2020","unstructured":"Newell-Price J, Nieman LK, Reincke M, Tabarin A. Endocrinology in the time of COVID-19: Management of cushing\u2019s syndrome. Eur J Endocrinol. 2020;183:G1-7.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR102","doi-asserted-by":"crossref","unstructured":"Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020a;33:e13365.","DOI":"10.1111\/dth.13365"},{"key":"9715_CR103","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jocd.13443","volume":"19","author":"A Goren","year":"2020","unstructured":"Goren A, Va\u00f1o-Galv\u00e1n S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, et al. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020;19:1545\u20137.","journal-title":"J Cosmet Dermatol"},{"key":"9715_CR104","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jsxm.2021.03.004","volume":"18","author":"JM Auerbach","year":"2021","unstructured":"Auerbach JM, Khera M. Testosterone\u2019s Role in COVID-19. J Sex Med. 2021;18:843\u20138.","journal-title":"J Sex Med"},{"key":"9715_CR105","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","volume":"198","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol. 2017;198:4046\u201353.","journal-title":"J Immunol"},{"key":"9715_CR106","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/2159-8290.CD-20-0451","volume":"10","author":"KH Stopsack","year":"2020","unstructured":"Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? Cancer Discov. 2020;10:779\u201382.","journal-title":"Cancer Discov"},{"key":"9715_CR107","doi-asserted-by":"crossref","unstructured":"Younis JS, Skorecki K, Abassi Z. The double edge sword of testosterone's role in the COVID-19 pandemic. Front Endocrinol (Lausanne). 2021;12:607179.","DOI":"10.3389\/fendo.2021.607179"},{"key":"9715_CR108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12020-021-02623-2","volume":"71","author":"PJ Niemann","year":"2021","unstructured":"Niemann PJ, Goldstein HV. Testosterone in COVID-19: Friend or foe? Endocrine. 2021;71:281\u20132.","journal-title":"Endocrine"},{"key":"9715_CR109","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"9715_CR110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685\u201397.","journal-title":"Lancet"},{"key":"9715_CR111","first-page":"254","volume":"41","author":"SF De Medeiros","year":"2015","unstructured":"De Medeiros SF, Barbosa JS, Yamamoto MM. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women. J ObstetGynaecol Res. 2015;41:254\u201363.","journal-title":"J ObstetGynaecol Res"},{"key":"9715_CR112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11325-019-01835-1","volume":"24","author":"H Kahal","year":"2020","unstructured":"Kahal H, Kyrou I, Uthman OA, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020;24:339\u201350.","journal-title":"Sleep Breath"},{"key":"9715_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2003.01842.x","volume":"60","author":"T Tsilchorozidou","year":"2004","unstructured":"Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2004;60:1\u201317.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9715_CR114","first-page":"3","volume":"20","author":"MMW Yamamoto","year":"2019","unstructured":"Yamamoto MMW, de Medeiros SF. Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome. Rev Endocr Metab Disord. 2019;20:3\u201313.","journal-title":"Rev EndocrMetabDisord"},{"key":"9715_CR115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cen.13828","volume":"89","author":"EW Gilbert","year":"2018","unstructured":"Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews. Clin Endocrinol (Oxf). 2018;89:683\u201399.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9715_CR116","doi-asserted-by":"crossref","unstructured":"Moin ASM, Sathyapalan T, Butler AE, Atkin SL. Vitamin D association with macrophage-derived cytokines in polycystic ovary syndrome: An enhanced risk of COVID-19 infection?.\u00a0Front Endocrinol (Lausanne). 2021;12:638621.","DOI":"10.3389\/fendo.2021.638621"},{"key":"9715_CR117","doi-asserted-by":"crossref","unstructured":"Morgante G, Tro\u00eca L, De Leo V. Coronavirus disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? J Steroid Biochem Mol Biol. 2021;205:105770.","DOI":"10.1016\/j.jsbmb.2020.105770"},{"key":"9715_CR118","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jog.13250","volume":"43","author":"G Reis","year":"2017","unstructured":"Reis G, Dos OP, Gontijo N, Rodrigues K, Alves M, Ferreira C, et al. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review. J Obstet Gynaecol Res. 2017;43:436\u201346.","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"9715_CR119","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0043-103573","volume":"49","author":"M Azadi-Yazdi","year":"2017","unstructured":"Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H, Salehi-Abargouei A. The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: A systematic review and meta-analysis of clinical trials. Horm Metab Res. 2017;49:174\u20139.","journal-title":"Horm Metab Res"},{"key":"9715_CR120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu12040988","volume":"12","author":"W Grant","year":"2020","unstructured":"Grant W, Lahore H, McDonnell S, Baggerly C, French C, Aliano J, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988.","journal-title":"Nutrients"},{"key":"9715_CR121","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40520-020-01570-8","volume":"32","author":"PC Ilie","year":"2020","unstructured":"Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020;32:1195\u20138.","journal-title":"Aging Clin Exp Res"},{"key":"9715_CR122","first-page":"6","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. FertilSteril. 2016;106:6\u201315.","journal-title":"FertilSteril"},{"key":"9715_CR123","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/ijms22094472","volume":"22","author":"AM Huffman","year":"2021","unstructured":"Huffman AM, Rezq S, Basnet J, Yanes Cardozo LL, Romero DG. SARS-CoV-2 Viral entry proteins in hyperandrogenemic female mice: Implications for women with PCOS and COVID-19. Int J Mol Sci. 2021;22:4472.","journal-title":"Int J Mol Sci"},{"key":"9715_CR124","doi-asserted-by":"crossref","unstructured":"H\u00e4ggl\u00f6f C, Hammarsten P, Str\u00f6mvall K, Egevad L, Josefsson A, Stattin P, et al. TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLoS One. 2014;9:e86824.","DOI":"10.1371\/journal.pone.0086824"},{"key":"9715_CR125","first-page":"2948","volume":"21","author":"S La Vignera","year":"2020","unstructured":"La Vignera S, Cannarella R, Condorelli R, Torre F, Aversa A, Calogero A. Sex-specific SARS-CoV2 mortality: Among hormone-modulated ace2 expression, risk of venous thromboembolism and hypovitaminosis D. Int J MolSci. 2020;21:2948.","journal-title":"Int J MolSci"},{"key":"9715_CR126","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020;202:756\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"9715_CR127","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u201380.e8.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"9715_CR128","doi-asserted-by":"crossref","first-page":"F243","DOI":"10.1152\/ajprenal.00601.2020","volume":"320","author":"LL Yanes Cardozo","year":"2021","unstructured":"Yanes Cardozo LL, Rezq S, Pruett JE, Romero DG. Androgens, the kidney, and COVID-19: an opportunity for translational research. Am J Physiol Renal Physiol. 2021;320:F243\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"9715_CR129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12967-020-02669-2","volume":"18","author":"ASM Moin","year":"2020","unstructured":"Moin ASM, Sathyapalan T, Atkin SL, Butler AE. COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2020;18:490.","journal-title":"J Transl Med"},{"key":"9715_CR130","doi-asserted-by":"crossref","unstructured":"Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Renin-angiotensin system overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection? Metabol Open. 2020b;7:100052.","DOI":"10.1016\/j.metop.2020.100052"},{"key":"9715_CR131","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/jdv.17004","volume":"35","author":"FA Cadegiani","year":"2021","unstructured":"Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, et al. Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. J Eur Acad Dermatol Venereol. 2021;35:e101\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9715_CR132","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41574-020-0364-6","volume":"16","author":"N Stefan","year":"2020","unstructured":"Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16:341\u20132.","journal-title":"Nat Rev Endocrinol"},{"key":"9715_CR133","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-20-0541","volume":"183","author":"M Rottoli","year":"2020","unstructured":"Rottoli M, Bernante P, Belvedere A, et al. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Eur J Endocrinol. 2020;183:389\u201397.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.696087","author":"Y Yang","year":"2021","unstructured":"Yang Y, Cai Z, Zhang J. Insulin treatment may increase adverse outcomes in patients with COVID-19 and diabetes: a meta-analysis. Front Endocrinol. 2021. https:\/\/doi.org\/10.3389\/fendo.2021.696087.","journal-title":"Front Endocrinol"},{"key":"9715_CR135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362.","journal-title":"Nat Rev Immunol"},{"key":"9715_CR136","unstructured":"Bertuccioli A, Balducci D, Bressan A. COVID-19, interleukin-6, androgen receptor and the adipose organ: what are the possible targets of this association? Nutrafoods. 2020;2:176\u201376."},{"key":"9715_CR137","doi-asserted-by":"crossref","unstructured":"Yang J, Hu J, Zhu C. Obesity aggravates COVID\u201019: A systematic review and meta\u2010analysis. J Med Virol. 2020;jmv.26237.","DOI":"10.1002\/jmv.26237"},{"key":"9715_CR138","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430\u20136.","journal-title":"Nature"},{"key":"9715_CR139","doi-asserted-by":"crossref","unstructured":"Daryabor G, Kabelitz D, Kalantar K. An update on immune dysregulation in obesity-related insulin resistance. Scand J Immunol. 2019;89:e12747.","DOI":"10.1111\/sji.12747"},{"key":"9715_CR140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/obr.12320","volume":"16","author":"NV Dhurandhar","year":"2015","unstructured":"Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev. 2015;16:1017\u201329.","journal-title":"Obes Rev"},{"key":"9715_CR141","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363\u201374.","journal-title":"Nat Rev Immunol"},{"key":"9715_CR142","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41423-020-0375-1","volume":"17","author":"AO Brien","year":"2020","unstructured":"Brien AO, Kedia-Mehta N, Tobin L, Veerapen N, Besra GS, Shea DO, et al. Targeting mitochondrial dysfunction in MAIT cells limits IL-17 production in obesity. Cell Mol Immunol. 2020;17:1193\u20135.","journal-title":"Cell Mol Immunol"},{"key":"9715_CR143","doi-asserted-by":"crossref","unstructured":"Parrot T, Gorin JB, Ponzetta A, Maleki KT, Kammann T, Emg\u00e5rd J, et al. MAIT cell activation and dynamics associated with COVID-19 disease severity. Sci Immunol. 2020;5:eabe1670.","DOI":"10.1101\/2020.08.27.20182550"},{"key":"9715_CR144","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.peptides.2014.09.006","volume":"61","author":"A Stengel","year":"2014","unstructured":"Stengel A, Goebel-Stengel M, Teuffel P, Hofmann T, Bu\u00dfe P, Kobelt P, et al. Obese patients have higher circulating protein levels of dipeptidyl peptidase IV. Peptides. 2014;61:75\u201382.","journal-title":"Peptides"},{"key":"9715_CR145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020;9:601\u20134.","journal-title":"Emerg Microbes Infect"},{"key":"9715_CR146","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/oby.22831","volume":"28","author":"A Simonnet","year":"2020","unstructured":"Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020;28:1195\u20139.","journal-title":"Obesity (Silver Spring)"},{"key":"9715_CR147","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","volume":"118","author":"PD Stein","year":"2005","unstructured":"Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118:978\u201380.","journal-title":"Am J Med"},{"key":"9715_CR148","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","volume":"142","author":"N Sattar","year":"2020","unstructured":"Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: Multiple potential mechanisms. Circulation. 2020;142:4\u20136.","journal-title":"Circulation"},{"key":"9715_CR149","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/s41366-020-0624-5","volume":"44","author":"S Cinti","year":"2020","unstructured":"Cinti S, Graciotti L, Giordano A, Valerio A, Nisoli E. COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity. Int J Obes. 2020;44:1800\u20132.","journal-title":"Int J Obes"},{"key":"9715_CR150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fendo.2020.00530","volume":"11","author":"G Pasquarelli-do-Nascimento","year":"2020","unstructured":"Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalh\u00e3es KG. Hypercoagulopathy and adipose tissue exacerbated inflammation may explain higher mortality in COVID-19 patients with obesity. Front Endocrinol. 2020;11:530.","journal-title":"Front Endocrinol"},{"key":"9715_CR151","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fpubh.2020.00351","volume":"8","author":"V Frisardi","year":"2020","unstructured":"Frisardi V. Commentary: coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection? Front Public Health. 2020;8:351.","journal-title":"Front Public Health"},{"key":"9715_CR152","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","volume":"75","author":"JJ Zhang","year":"2020","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. 2020;75:1730\u201341.","journal-title":"China Allergy"},{"key":"9715_CR153","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsgi.2004.09.003","volume":"12","author":"V Sepilian","year":"2005","unstructured":"Sepilian V, Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig. 2005;12:129\u201334.","journal-title":"J Soc Gynecol Investig"},{"key":"9715_CR154","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00404-020-05867-x","volume":"303","author":"SF de Medeiros","year":"2021","unstructured":"de Medeiros SF, de Medeiros MAS, Barbosa BB, Yamamoto MMW, Maciel GAR. Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome. Arch Gynecol Obstet. 2021;303:739\u201349.","journal-title":"Arch Gynecol Obstet"},{"key":"9715_CR155","first-page":"495","volume":"21","author":"M Marazuela","year":"2020","unstructured":"Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020;21:495\u2013507.","journal-title":"Rev EndocrMetabDisord"},{"key":"9715_CR156","doi-asserted-by":"crossref","unstructured":"Emani A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch AcadEmerg Med. 2020;8:e35.","DOI":"10.1371\/journal.pone.0241265"},{"key":"9715_CR157","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"9715_CR158","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","volume":"47","author":"JK Yang","year":"2010","unstructured":"Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193\u20139.","journal-title":"Acta Diabetol"},{"key":"9715_CR159","doi-asserted-by":"crossref","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.","DOI":"10.1136\/bmj.m1966"},{"key":"9715_CR160","first-page":"211","volume":"14","author":"R Gupta","year":"2020","unstructured":"Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes MetabSyndr. 2020;14:211\u20132.","journal-title":"Diabetes MetabSyndr"},{"key":"9715_CR161","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"9715_CR162","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","volume":"16","author":"SR Bornstein","year":"2020","unstructured":"Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020;16:297\u20138.","journal-title":"Nat Rev Endocrinol"},{"key":"9715_CR163","doi-asserted-by":"crossref","unstructured":"Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68:2\u20135.","DOI":"10.1007\/s12020-020-02294-5"},{"key":"9715_CR164","doi-asserted-by":"crossref","unstructured":"i MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9:45.","DOI":"10.1186\/s40249-020-00662-x"},{"key":"9715_CR165","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/dme.14316","volume":"37","author":"G Rayman","year":"2020","unstructured":"Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. Guidelines for the management of diabetes services and patients during the COVID-19 pandemic. Diabet Med. 2020;37:1087\u20139.","journal-title":"Diabet Med"},{"key":"9715_CR166","first-page":"E736","volume":"318","author":"R Muniyappa","year":"2020","unstructured":"Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020;318:E736\u201341.","journal-title":"Am J PhysiolEndocrinolMetab"},{"key":"9715_CR167","first-page":"451","volume":"21","author":"WS Azar","year":"2020","unstructured":"Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, et al. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev Endocr Metab Disord. 2020;21:451\u201363.","journal-title":"Rev EndocrMetabDisord"},{"key":"9715_CR168","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/dme.14300","volume":"37","author":"RCW Ma","year":"2020","unstructured":"Ma RCW, Holt RIG. COVID-19 and diabetes. Diabet Med. 2020;37:723\u20135.","journal-title":"Diabet Med"},{"key":"9715_CR169","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259\u201365.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9715_CR170","doi-asserted-by":"crossref","first-page":"759","DOI":"10.15585\/mmwr.mm6924e2","volume":"69","author":"EK Stokes","year":"2020","unstructured":"Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai FS, et al. Coronavirus disease 2019 case surveillance - United States, 22 Jan\u00a0\u2013 30 May\u00a02020. MMWR Morb Mortal Wkly Rep. 2020;69:759\u201365.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9715_CR171","doi-asserted-by":"crossref","unstructured":"Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020:e3319.","DOI":"10.1002\/dmrr.3319"},{"key":"9715_CR172","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fpubh.2020.00184","volume":"8","author":"FM Finucane","year":"2020","unstructured":"Finucane FM, Davenport C. Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection? Front Public Health. 2020;8:184.","journal-title":"Front Public Health"},{"key":"9715_CR173","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000345107","volume":"59","author":"S Knapp","year":"2013","unstructured":"Knapp S. Diabetes and infection: is there a link?\u2013A mini-review. Gerontology. 2013;59:99\u2013104.","journal-title":"Gerontology"},{"key":"9715_CR174","unstructured":"Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab. 1992;18:187\u201301."},{"key":"9715_CR175","doi-asserted-by":"crossref","unstructured":"Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142.","DOI":"10.1016\/j.diabres.2020.108142"},{"key":"9715_CR176","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/MJBL.MJBL_32_18","volume":"15","author":"S Al-Musawy","year":"2018","unstructured":"Al-Musawy S, Al-Saimary I, Flaifil M. Levels of cytokines profile in polycystic ovary syndrome. Med J Babylon. 2018;15:124\u20138.","journal-title":"Med Jl Babylon"},{"key":"9715_CR177","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc20-0643","volume":"43","author":"S Rao","year":"2020","unstructured":"Rao S, Lau A, So H. Exploring diseases\/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: A mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care. 2020;43:1416\u201326.","journal-title":"Diabetes Care"},{"key":"9715_CR178","doi-asserted-by":"crossref","unstructured":"Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: A possible role beyond diabetes. Diabetes Res Clin Pract. 2020;164:108183.","DOI":"10.1016\/j.diabres.2020.108183"},{"key":"9715_CR179","doi-asserted-by":"crossref","unstructured":"Drucker DJ. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev. 2020;41:bnaa011.","DOI":"10.1210\/endrev\/bnaa011"},{"key":"9715_CR180","first-page":"137","volume":"56","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Choi YM. Dyslipidemia in women with polycystic ovary syndrome. Obstet Gynecol Sci. 2013;56:137\u201342.","journal-title":"ObstetGynecol Sci"},{"key":"9715_CR181","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s10067-020-05301-2","volume":"39","author":"CS Santos","year":"2020","unstructured":"Santos CS, Morales CM, \u00c1lvarez ED, Castro C\u00c1, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol. 2020;39:2789\u201396.","journal-title":"Clin Rheumatol"},{"key":"9715_CR182","doi-asserted-by":"crossref","unstructured":"Hu X, Chen D, Wu L,He L, Wei GYe.\u00a0Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China. China.\u00a02020.","DOI":"10.2139\/ssrn.3544826"},{"key":"9715_CR183","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","volume":"58","author":"Q Liu","year":"2019","unstructured":"Liu Q, Xie YJ, Qu LH, Zhang MX, Mo ZC. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58:447\u201353.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"9715_CR184","doi-asserted-by":"crossref","unstructured":"Bramante C, Tignanelli C, Dutta N, Jones E, Tamariz L, Clark J, et al. Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19. medRxiv. 2020.09.01.20185850","DOI":"10.1101\/2020.09.01.20185850"},{"key":"9715_CR185","doi-asserted-by":"crossref","unstructured":"Kumarendran B, O\u2019Reilly M, Manolopoulos K, Toulis K, Gokhale K, Sitch A, et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med. 2018;15:e1002542","DOI":"10.1371\/journal.pmed.1002542"},{"key":"9715_CR186","first-page":"69","volume":"154","author":"R Zeiser","year":"2018","unstructured":"Zeiser R. Immune modulatory effects of statins Immunology. 2018;154:69\u201375.","journal-title":"Immune modulatory effects of statins Immunology"},{"key":"9715_CR187","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","volume":"99","author":"DS Feldson","year":"2013","unstructured":"Feldson DS. Treating influenza with statins and other immunomodulatory agents. Antiviral Res. 2013;99:417\u201335.","journal-title":"Antiviral Res"},{"key":"9715_CR188","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318:H1084\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9715_CR189","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCRESAHA.121.318054","volume":"128","author":"C Savoia","year":"2021","unstructured":"Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: Current views and perspectives. Circ Res. 2021;128:1062\u201379.","journal-title":"Circ Res"},{"key":"9715_CR190","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/jch.13925","volume":"22","author":"M Tadic","year":"2020","unstructured":"Tadic M, Cuspidi C, Grassi G, Mancia G. COVID-19 and arterial hypertension: Hypothesis or evidence? J Clin Hypertens (Greenwich). 2020;22:1120\u20136.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"9715_CR191","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","volume":"33","author":"HS Randeva","year":"2012","unstructured":"Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev. 2012;33:812\u201341.","journal-title":"Endocr Rev"},{"key":"9715_CR192","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2011.01.009","volume":"40","author":"R Bentley-Lewis","year":"2011","unstructured":"Bentley-Lewis R, Seely E, Dunaif A. Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2011;40:433\u2013x.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9715_CR193","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19. N Engl J Med. 2020;382:2441\u20138.","journal-title":"N Engl J Med"},{"key":"9715_CR194","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","volume":"18","author":"M Amiri","year":"2020","unstructured":"Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020;18:23.","journal-title":"Reprod Biol Endocrinol"},{"key":"9715_CR195","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of COVID-19. N Engl J Med. 2020;382:2431\u201340.","journal-title":"N Engl J Med"},{"key":"9715_CR196","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000513886","volume":"14","author":"AP Simopoulos","year":"2021","unstructured":"Simopoulos AP. Genetic variation, diet, inflammation, and the risk for COVID-19. Lifestyle Genom. 2021;14:37\u201342.","journal-title":"Lifestyle Genom"},{"key":"9715_CR197","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41366-020-0597-4","volume":"44","author":"S Chiappetta","year":"2020","unstructured":"Chiappetta S, Sharma AM, Bottino V, Stier C. COVID-19 and the role of chronic inflammation in patients with obesity. Int J Obes (Lond). 2020;44:1790\u20132.","journal-title":"Int J Obes (Lond)"},{"key":"9715_CR198","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/cen.12951","volume":"83","author":"M Liu","year":"2015","unstructured":"Liu M, Gao J, Zhang Y, Li P, Wang H, Ren X, et al. Serum levels of TSP-1, NF-\u03baB and TGF-\u03b21 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation. Clin Endocrinol (Oxf). 2015;83:913\u201322.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9715_CR199","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1073\/pnas.1920004117","volume":"117","author":"MS Han","year":"2020","unstructured":"Han MS, White A, Perry RJ, Camporez JP, Hidalgo J, Shulman GI, et al. Regulation of adipose tissue inflammation by interleukin 6. Proc Natl Acad Sci U S A. 2020;117:2751\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9715_CR200","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.18535\/ijmsci\/v8i05.05","volume":"8","author":"G Arusoglu","year":"2021","unstructured":"Arusoglu G, Bozay K. The immune system response in Covid-19 infection in polycystic ovary syndrome. Int J Med Sci Clin Invest. 2021;8:5380\u20136.","journal-title":"Int J Med Sci Clin Invest"},{"key":"9715_CR201","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1530\/EJE-20-0665","volume":"183","author":"JP Bilezikian","year":"2020","unstructured":"Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: Vitamin D and COVID-19. Eur J Endocrinol. 2020;183:R133\u201347.","journal-title":"Eur J Endocrinol"},{"key":"9715_CR202","first-page":"2641","volume":"19","author":"CY Miao","year":"2020","unstructured":"Miao CY, Fang XJ, Chen Y, Zhang Q. Effect of vitamin D supplementation on polycystic ovary syndrome: A meta-analysis. Exp Ther Med. 2020;19:2641\u20139.","journal-title":"Exp Ther Med"},{"key":"9715_CR203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fendo.2019.00013","volume":"10","author":"TK Cunningham","year":"2019","unstructured":"Cunningham TK, Allgar V, Dargham SR, Kilpatrick E, Sathyapalan T, Maguiness S, et al. Association of vitamin D metabolites with embryo development and fertilization in women with and without PCOS undergoing subfertility treatment. Front Endocrinol (Lausanne). 2019;10:13.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9715_CR204","first-page":"81","volume":"113","author":"E Laird","year":"2020","unstructured":"Laird E, Rhodes J, Kenny RA. Vitamin D and inflammation: Potential implications for severity of covid-19. Ir Med J. 2020;113:81.","journal-title":"Ir Med J"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09715-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-022-09715-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09715-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:05:40Z","timestamp":1726740340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-022-09715-y"}},"subtitle":["PCOS and COVID-19 relationship"],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":204,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["9715"],"URL":"https:\/\/doi.org\/10.1007\/s11154-022-09715-y","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,26]]},"assertion":[{"value":"1 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare there are no financial or other conflicts of interest that could be perceived as prejudicing the impartiality of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}